Post-marketing Safety Study of mRNA-1283 in the United States

08/04/2026
08/04/2026
EU PAS number:
EUPAS1000000971
Study
Planned
Study identification

EU PAS number

EUPAS1000000971

Study ID

1000000971

Official title and acronym

Post-marketing Safety Study of mRNA-1283 in the United States

DARWIN EU® study

No

Study countries

United States

Study description

No information provided.

Study status

Planned

Contact details

Clinical Trial Disclosure ModernaTX

Primary lead investigator

Study timelines

Date when funding contract was signed

Actual:

Study start date

Planned:

Date of final study report

Planned:
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

EU RMP category 3 (required)